VBI Vaccines downgraded by Raymond James with a new price target

11/11/22 7:30:44 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Raymond James downgraded VBI Vaccines from Strong Buy to Outperform and set a new price target of $2.00 from $5.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VBIV

Date	Price Target	Rating	Analyst
11/11/2022	$5.00 → $2.00	Strong Buy → Outperform	Raymond James
3/8/2022	$9.00 → $6.00	Strong Buy	Raymond James
12/29/2021	$7.00 → $6.00	Buy	Jefferies